Machine Learning Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule… GlobeNewswire Apr 13, 2023 Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has…
Machine Learning Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed… AIT News Desk Feb 9, 2023 Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, announced that the…
Machine Learning Insilico Medicine Announces Positive Topline Results Of The New Zealand Phase 1 Trial Of INS018_055,… AIT News Desk Jan 11, 2023 Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug R&D company, announces positive topline results of…
Machine Learning Insilico Medicine Nominates Preclinical Candidate Targeting KAT6A for ER+/HER2- Breast Cancer… AIT News Desk Dec 28, 2022 Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced that the company's…
Machine Learning Insilico Medicine Applauded By Frost & Sullivan For Enabling Rapid And Cost-Effective Drug… AIT News Desk Jan 25, 2022 The Pharma.AI platform combining deep generative models (GAN), reinforcement learning (RL), transformers, and other modern machine learning techniques…
News Insilico Medicine and ChemDiv Form a Strategic Drug Discovery Service Alliance AIT News Desk Oct 16, 2019 Insilico Medicine and ChemDiv, Inc. launched a new strategic collaboration to provide certain pharmaceutical and biotechnology companies with…